Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ultra Tab Laboratories is a pharmaceutical contract manufacturing organization (CMO) specializing in the development and production of over-the-counter (OTC) solid dose medications. Based in Highland, New York, the company operates an FDA-registered, cGMP-compliant facility that provides end-to-end services including formulation, high-speed tableting, encapsulation, and packaging. The company is recognized for its ability to handle high-volume production for both private label and branded pharmaceutical products. In August 2021, Ultra Tab Laboratories was acquired by Geri-Care Pharmaceuticals to expand Geri-Care's internal manufacturing capabilities and broaden its product offerings in the healthcare market. Its core expertise lies in small molecule manufacturing for therapeutic areas such as pain management, allergy relief, and digestive health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ULTRAtab.